<DOC>
	<DOCNO>NCT00014651</DOCNO>
	<brief_summary>RATIONALE : Drugs vapreotide may prevent complication follow pancreatic resection . It yet know vapreotide effective therapy prevent side effect pancreatic resection . PURPOSE : This randomized phase III trial study vapreotide see well work compare placebo prevent complication patient undergo surgery pancreatic cancer .</brief_summary>
	<brief_title>Vapreotide Treating Patients Undergoing Elective Pancreatic Resection</brief_title>
	<detailed_description>OBJECTIVES : I . Compare efficacy vapreotide versus placebo reduce postoperative pancreatic complication patient undergo elective pancreatic resection . II . Compare postoperative complication occur within 45 day surgery unrelated pancreas , day hospitalization survival 45 day surgery , number rehospitalizations , number postoperative blood unit pack red blood cell administer patient treated regimen . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients randomize one two treatment arm . Arm I : Patients undergo surgical resection day 1 receive vapreotide subcutaneously twice daily day 1-7 . Arm II : Patients undergo surgical resection receive placebo arm I . Patients follow day 28 45 . PROJECTED ACCRUAL : A total 580 patient ( 290 per arm ) accrue study .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Vapreotide</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Planned elective pancreatic resection due presume pancreatic tumor ( either proximal distal pancreatic lesion ) presume neoplasm ampullary periampullary region Require perianastomotic drain ( ) near pancreaticoenterostomy near pancreatic stump closure The follow exclude : Emergency surgery pancreas ( acute pancreatitis , pancreatic trauma ) Known chronic pancreatitis ( pancreatic cancer duct obstructive chronic pancreatitis allow ) Need total pancreatectomy Need pancreatic transplantation Need elective pancreaticcyst anastomosis Need pancreatic duct drainage operation without resection ( pancreatic stent allow perform partial pancreatic resection ) Enucleation pancreatic neoplasm PATIENT CHARACTERISTICS : Age : 18 90 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Bilirubin great 2.0 mg/dL Renal : Creatinine great 2 time upper limit normal Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No neoadjuvant postoperative adjuvant chemotherapy 2 week 2 week surgery Endocrine therapy : At least 4 week since prior somatostatin somatostatin analogue No concurrent somatostatin somatostatin analogue Radiotherapy : No neoadjuvant postoperative adjuvant radiotherapy 2 week 2 week surgery Surgery : See Disease Characteristics Other : No concurrent pancreatic enzyme inhibitor ( e.g. , antiproteases ) No concurrent immunosuppressive agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>perioperative/postoperative complication</keyword>
	<keyword>stage I pancreatic cancer</keyword>
</DOC>